Skip to main content

Day: November 29, 2021

Jura Announces Release of Interim Filings and Operational Update

CALGARY, Alberta, Nov. 29, 2021 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura”) today announced the filing on SEDAR of its condensed consolidated interim financial statements as at, and for the three and nine months period ended September 30, 2021 and 2020, and its management’s discussion and analysis for the third quarter of fiscal year 2021. Operational Update During the three months period ended September 30, 2021, the gas production from the Zarghun South lease was dropped significantly. The decline in gas production is attributed to a significant drop in wellhead flowing pressures and excessive formation water production caused by a water breakthrough in the naturally fractured Dunghan reservoir. Jura holds a 40% working interest in the Zarghun South lease through its wholly-owned subsidiary Spud Energy Pty Limited, and...

Continue reading

Assess the Impact of Global Push for Electrification at Wood Mackenzie’s Grid Edge Innovation Series

Sector Leaders to Join Consultancy’s Experts at New Event LONDON/HOUSTON/SINGAPORE, Nov. 29, 2021 (GLOBE NEWSWIRE) — Wood Mackenzie, a Verisk business (Nasdaq:VRSK), to launch the Grid Edge Innovation Series. Electrification and decarbonization are now not just a priority for grid operators and energy regulators, but at national and international levels. The tools and technologies at the grid edge hold an enormous potential to contribute to emissions reduction and energy efficiency goals by better integrating distributed power generation, enabling grid flexibility. Join Wood Mackenzie virtually for a series of short, topical and insightful sessions running from 2 December until 16 December. Wood Mackenzie’s experts and representatives from the leading distribution utilities, software technology developers, public utility commissions...

Continue reading

CE Brands Announces Rescheduled Second Quarter 2022 Shareholder Update Call

CALGARY, Alberta, Nov. 29, 2021 (GLOBE NEWSWIRE) — CE Brands Inc. (TSXV: CEBI; CEBI.WT) (“CE Brands”, “we”, “our”, or the “Company”), a data-driven consumer-electronics company, announces the rescheduling of its investor conference call originally scheduled for 9:00am PST (12:00 pm EDT) today, due to an unexpected scheduling conflict. CE Brands will host a virtual-only shareholder update call on Tuesday, December 7th, at 9-10am PST (12-1pm EST). The shareholder update call will be facilitated by Craig Smith, CEO and Kalvie Legat, CFO, who will review the company’s second quarter financial results and related operational matters. The Company will answer pre-submitted questions at the conclusion of prepared remarks. Investors are asked to submit their questions in advance to ir@cebrands.ca. You can join the shareholder update...

Continue reading

Overstock to Participate in Credit Suisse 25th Annual Technology Conference

SALT LAKE CITY, Nov. 29, 2021 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) a leading e-commerce home furnishings retailer announced its participation in the Credit Suisse 25th Annual Technology Conference. Jonathan Johnson, Chief Executive Officer, and Adrianne Lee, Chief Financial Officer, will participate in investor meetings. “In the third quarter of 2021, Overstock continued to profitably grow market share as a result of the significant, foundational operational changes we have made to the business over the past year and a half,” said Johnson. “We look forward to this opportunity to tell our story to the investment community and thank Credit Suisse for hosting us at this event.” Credit Suisse Annual Technology Conference is the largest technology investor conference and will take place on November 29 to December 2,...

Continue reading

AB Science announces dosing of first patient in Phase 2 trial of masitinib’s antiviral activity against the SARS-CoV-2 (COVID-19) virus

PRESS RELEASE AB SCIENCE ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 2 TRIAL OF MASITINIB’S ANTIVIRAL ACTIVITY AGAINST THE SARS-CoV-2 (COVID-19) VIRUS Paris, 29 November, 2021, 8.45pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that the first patient has been dosed in the phase 2 trial evaluating the antiviral activity of masitinib in patients who have a confirmed diagnosis of COVID-19. The study plans to enroll 78 patients, either non-hospitalized patients with mild disease or hospitalized patients without requirement for non-invasive ventilation. The primary efficacy objective will be to demonstrate that masitinib can reduce the viral load of SARS-CoV-2 (the virus responsible for COVID-19) faster than a placebo control group, which will receive best supportive care. Study AB21002 has been authorized so...

Continue reading

Inscape Corporation Will Release Second Quarter Results for the 2022 Financial Year

HOLLAND LANDING, Ontario, Nov. 29, 2021 (GLOBE NEWSWIRE) — (TSX:INQ) Inscape Corporation will release its Second Quarter Results for the 2022 Financial Year after the close of business on Thursday, December 9, 2021. About Inscape The Company is an office furniture manufacturer with production at two facilities in Canada and the United States in approximately 338,000 square feet of space. The Company serves its clients through a network of dealers and representatives supported by showrooms across North America. The Company reports in two reportable operating segments. The Office Furniture segment includes storage, benching, systems and seating solutions products. The Walls segment includes architectural and movable walls. FOR FURTHER INFORMATION, PLEASE CONTACT: Inscape CorporationJon SzczurChief Financial Officer(905) 952-4102

Continue reading

Proactive news headlines including CULT Food Science, TRACON Pharmaceuticals, Vanstar Mining Resources, Etruscus Resources and BetterLife Pharma

New York, Nov. 29, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Canada Silver Cobalt extends strike length at Graal property in Northern Quebec as it targets EV and critical metals development click here Todos Medical strikes deal with NLC Pharma for groundbreaking 3CL protease biology-related assets; announces plans to form subsidiary click here Forward Water Technologies CEO says the company is seeing ‘rapidly growing interest’ in various wastewater sectors click here CULT Food Science says its portfolio company Biftek reported significant progress in global commercialization of its growth medium supplements click here Mountain Boy Minerals reveals new drill results showing high zinc and gold...

Continue reading

OTC: DRCR, Swifty Global (Dear Cashmere Holding Company), Announces the Launch of Its Public Beta Testing Phase

NEW YORK, Nov. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Dear Cashmere Holding Company (OTC: DRCR) known as Swifty Global, is a technology company focused on creating ground-breaking solutions in the Financial and Sports Betting Sectors. The company has developed two disruptive mobile applications (apps) for sports predictions and a digital wallet which encompasses Artificial Intelligence (AI) and Cryptocurrency/Blockchain Transactions. Patent applications have already been submitted and the mobile apps will be launched following successful Public Beta testing and the approval of Swifty Global’s imminent first gambling license. Swifty Global (Swifty) has been verbally notified that its first gambling license has been approved and that the company can expect the official documentation in the coming days, at which time...

Continue reading

Ultimovacs ASA: Mandatory notification of trade by primary insider

Oslo, 29 November 2021, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs ASA, has today bought 1,000 shares in the company at a price of NOK 114.00 per share, and a closely related party has today bought 1,000 shares in the company at a price of NOK 114.00 per share. Following this transaction, Carlos de Sousa and closely related parties hold 14,056 shares and 416,035 share options in Ultimovacs ASA. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading Act.  Attachments20211129 – Ultimovacs Notification of trade – KRT-1500 220211129 – Ultimovacs Notification of trade – KRT-1500 1

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.